GlassScriptPhysician profile
Sarah Mcandrew
NPI 1679921548
$2,098.68
in general payments reported to CMS, 2019-2025
13 companies · $341 in 2025
The $341 reported for 2025 was more than what 87% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
See the full distribution for Pediatrics (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $632 · 2024: $1,126 · 2025: $341.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,074 · Education: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,073.68 |
| Education | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $493.07 | 2023-2024 | |
| Novo Nordisk INC | $455.25 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $379.16 | 2023-2025 | Mounjaro, Zepbound, Jardiance |
| Ucb, INC. | $224.19 | 2025 | Bimzelx |
| Astrazeneca Pharmaceuticals LP | $178.81 | 2024 | Airsupra, Farxiga |
| Bayer Healthcare Pharmaceuticals INC. | $87.45 | 2024 | |
| Currax Pharmaceuticals LLC | $69.87 | 2023-2024 | Nexletol, Contrave, Nexlizet |
| Exact Sciences Corporation | $59.86 | 2023-2024 | Cologuard Collection Kit |
| Abbvie INC. | $49.56 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $42.02 | 2023-2024 | Xifaxan |
| Regeneron Healthcare Solutions, INC. | $24.46 | 2024 | Evkeeza |
| Dexcom, INC. | $17.91 | 2024 | Dexcom G6 Transmitter |
| Ani Pharmaceuticals, INC. | $17.07 | 2025 | Purified Cortrophin Gel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Mcandrew listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.